Sun Pharmaceutical Industries Ltd has announced the Un-Audited financial results for the quarter ended June 30, 2007.
The Company has posted a profit after tax of Rs 2253.90 million for the quarter ended June 30, 2007 as compared to Rs 1480.20 million for the quarter ended June 30, 2006. Total Income (Net of excise) has increased from Rs 5656.20 million for the quarter ended June 30, 2006 to Rs 7476.00 million for the quarter ended June 30, 2007.
The Consolidated results are as follows: The Group has posted a net profit after minority interest of Rs 2272.00 million for the quarter ended June 30, 2007 as compared to Rs 1767.30 million for the quarter ended June 30, 2006. Total Income (Net of excise) has increased from Rs 5385.70 million for the quarter ended June 30, 2006 to Rs 6880.50 million for the quarter ended June 30, 2007.
The stock was trading at Rs.990.50, up by Rs.10.30 or 1.05%. The stock hit an intraday high of Rs.999 and low of Rs.975. The total traded quantity was 101677 compared to 2 week average of 90956.